FDA Panel To Vote On First Multi-Cancer Blood Screening Test
1h
Developing
1
An FDA medical device advisory committee will vote on recommending approval of Grail's Galleri multi-cancer blood test on Wednesday, September 23, 2026, at an agency advisory meeting. NPR
